Author:
Haritz Dietrich,Otersen Birte,Grochulla Frank,Bergmann Markus,Huiskamp René,Preusse Dagmar,Gabel Detlef
Reference10 articles.
1. H. Hatanaka, Boron neutron capture therapy for tumors, in: “Glioma”, A.B.M. Karim, E. Laws, cds., Springer Verlag, New York, 1991, pp. 233–249.
2. G. Stragliotto, D. Schüpbach, P. Gavin, H. Fankhauscr, Update on biodistribution of BSH in patients with intracranial tumors, in: “Advances in Neutron Capture Therapy”, A.II. Soloway, R.F. Barth, D.E. Carpenter, eds., Plenum Press, New York, 1993, pp. 719–726.
3. C.P. Ceberg, A. Persson, A. Brun, R. Huiskamp, A.S. Fyhr, B.R.R. Persson, 1..G. Salford, Performance of BSH in patients with astrocytoma grades III-IV - a basis for boron neutron capture therapy, J. Neurosurgery, accepted for publication, 1994.
4. D. Haritz, D. Gabel, R. Huiskamp, Clinical phase-1 study of BSH in patients with malignant glioma as precondition for boron neutron capture therapy, Int. J. Radiation Oncology Biol. Phys., 28 (5): 1175–1181, 1994.
5. D. Joel, D. Slatkin, J. Coderre, Uptake of B-10 in gliosarcomas following the injection of glutathione monoethylester and sulfhydryl borane, in: “Advances in Neutron Capture Therapy”, A.H. Soloway, R.F. Barth, D.E. Carpenter, eds., Plenum Press, New York, 1993, pp. 501–505.